Insiders who reported open-market trades in the last 12 months at the companies Michael W. Bonney files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
Michael W. Bonney is a corporate insider, tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael W. Bonney last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 5 filings going back to 2025.
Has Michael W. Bonney been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($8.19M) across all tracked filings.
Michael W. Bonney is Director of Autolus Therapeutics plc (AUTL). 5 SEC Form 4 filings on record going back to 2025, most recently on 1 July 2026. Most recent open-market trade: sold $5.06M of ALNY on 18 August 2025. Lifetime open-market sales: $8.19M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Michael W. Bonney.
InsiderAlpha's records for Michael W. Bonney go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
